Chia Tai Tianqing Secures NMPA Approval for Phase III Trial of TQB2868 + Anlotinib in First‑Line mPDAC Therapy
CompanyDrug

Chia Tai Tianqing Secures NMPA Approval for Phase III Trial of TQB2868 + Anlotinib in First‑Line mPDAC Therapy

Lepu Biopharma Enrolls First Patient in Phase II Trial of MRG006A, the World’s First GPC3‑Targeting ADC
CompanyDrug

Lepu Biopharma Enrolls First Patient in Phase II Trial of MRG006A, the World’s First GPC3‑Targeting ADC

Jacobio Pharmaceuticals Secures 80% Equity Investment in Jacoray from Oceanpine Capital
CompanyDeals

Jacobio Pharmaceuticals Secures 80% Equity Investment in Jacoray from Oceanpine Capital

Zhejiang Authority Imposes Administrative Penalties on Dahongying Pharma for Substandard Fluorouracil Injection
Policy / Regulatory

Zhejiang Authority Imposes Administrative Penalties on Dahongying Pharma for Substandard Fluorouracil Injection

HELP Therapeutics Secures NMPA Approval for HiCM388, China’s First Cell‑Based Therapy for STEMI
CompanyDrug

HELP Therapeutics Secures NMPA Approval for HiCM388, China’s First Cell‑Based Therapy for STEMI

Abbott Reports Q3 2025 Revenue of $11.369 B, Up 6.9% YoY – Strong Growth Across Nutrition & Devices Segments
Company

Abbott Reports Q3 2025 Revenue of $11.369 B, Up 6.9% YoY – Strong Growth Across Nutrition & Devices Segments

Haihe Biopharma Grants Taiho Pharmaceutical Exclusive License for Risovalisib in Japan
CompanyDeals

Haihe Biopharma Grants Taiho Pharmaceutical Exclusive License for Risovalisib in Japan

Genesis Healthcare & MGI Sign Strategic MOU to Accelerate Precision Medicine in Japan
CompanyDeals

Genesis Healthcare & MGI Sign Strategic MOU to Accelerate Precision Medicine in Japan

Nuance Pharma Partners with Stallergenes Greer to Launch Actair in China
CompanyDeals

Nuance Pharma Partners with Stallergenes Greer to Launch Actair in China

Pfizer CEO Bourla Highlights Benefits of China Biotech Collaborations at NY Gala
Policy / Regulatory

Pfizer CEO Bourla Highlights Benefits of China Biotech Collaborations at NY Gala

Uni-Bio Science Partners with Sinovac to Expand Teriparatide Injection Globally
CompanyDeals

Uni-Bio Science Partners with Sinovac to Expand Teriparatide Injection Globally

Adagene Expands Exelixis Collaboration to Include Third Target Using SAFEbody Technology
CompanyDeals

Adagene Expands Exelixis Collaboration to Include Third Target Using SAFEbody Technology